Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis
Abstract To analyze the effectiveness and toxicities of radiotherapy in indolent non-Hodgkin’s lymphoma (iNHL) patients treated in our institution. Patients with iNHL treated with radiotherapy between 1999 and 2016 were included. The primary endpoint was progression-free survival (PFS). Secondary en...
Guardado en:
Autores principales: | I. Hadi, A. Schummer, M. Dreyling, C. Eze, R. Bodensohn, O. Roengvoraphoj, C. Belka, M. Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1140cde7c0a45d1aa60f5917fca5154 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice
por: Lali G. Babicheva, et al.
Publicado: (2020) -
ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA
por: Sanda Buruiana, et al.
Publicado: (2021) -
Hodgkin's lymphoma
por: E. A. Demina, et al.
Publicado: (2020) -
EVALUATION OF IMMUNE INDICES IN PATIENTS WITH INDOLENT AND AGGRESSIVE NON HODKIN`S LYMPHOMAS
por: A. V. Yovdiy, et al.
Publicado: (2014) -
Rituximab in the treatment of non-Hodgkin’s lymphoma
por: Beate Hauptrock, et al.
Publicado: (2008)